Overview

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

Status:
Completed

Trial end date:
2013-04-01

Target enrollment:

Participant gender:

Summary

To determine if co-administration of subcutaneous (SQ)Insulin glargine in combination with intravenous (IV) insulin decreases the time to resolution of ketoacidosis and requirement for ICU admission compared to IV insulin with delayed administration of SQ glargine for the treatment of diabetic ketoacidosis (DKA).

Phase:

N/A

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Treatments:

Insulin
Insulin Glargine
Insulin, Globin Zinc